TickerFactsScreenerDevelopers

Lineage Cell Therapeutics, Inc. (LCTX) — Revenue

Annual figures by fiscal year, from SEC filings.

2010: $3.71M2011: $4.43M2012: $3.92M2013: $4.43M2014: $5.24M2015: $7.04M2020: $1.83M2021: $4.34M2022: $14.70M2023: $8.95M2024: $9.50M2025: $14.56M$14.56M
2010Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$14.56M+53.2%
2024$9.50M+6.2%
2023$8.95M-39.2%
2022$14.70M+238.7%
2021$4.34M+137.7%
2020$1.83M—
2015$7.04M+34.2%
2014$5.24M+18.3%
2013$4.43M+13.2%
2012$3.92M-11.7%
2011$4.43M+19.6%
2010$3.71M—